- Page 1 and 2: Adherence to Treatment for HIVA Tra
- Page 3 and 4: © 2006 EngenderHealth Society.F-6/
- Page 5 and 6: TABLE OF CONTENTSPREFACEACKNOWLEDGE
- Page 7 and 8: PREFACEWith funding from the Global
- Page 9 and 10: ACKNOWLEDGEMENTSWe acknowledge with
- Page 11 and 12: ABBREVIATIONSARTCD4GFATMIVDUMSMNNRT
- Page 13 and 14: The Facilitator Guide consists of:
- Page 15 and 16: How to use the facilitator guideThe
- Page 17 and 18: This symbol indicatesthe questions
- Page 19 and 20: 8This box should becut and pasteona
- Page 21: This symbolindicates the triggerque
- Page 24 and 25: 1SECTION 1Section 1INTRODUCTIONS AN
- Page 26 and 27: 1SECTION 1Section 1INTRODUCTIONS AN
- Page 28 and 29: Section 1Then read out this definit
- Page 30 and 31: 1SECTION 1Section 1INTRODUCTIONS AN
- Page 32 and 33: Section 1Summarize the results as f
- Page 34 and 35: Section 22. During the discussion,
- Page 36 and 37: Section 2Where does HIV come from?N
- Page 38 and 39: 1SECTION 2Section 2HIV AND ANTIRETR
- Page 40 and 41: Section 210. You cannot contract HI
- Page 42 and 43: Section 2The list may include the f
- Page 44 and 45: Section 2• If you do not take you
- Page 46 and 47: Section 2Steps1. Ask the group if t
- Page 51 and 52: SCHEDULE FOR DAY 2Day Two : Resista
- Page 53 and 54: Section 3Explain thatART resistance
- Page 55 and 56: Section 322. Give the group the sum
- Page 57 and 58: Section 32SECTION 3RESISTANCE AND A
- Page 59 and 60: Section 32SECTION 3RESISTANCE AND A
- Page 61 and 62: Section 3Case Study #3Anand, a pers
- Page 63 and 64: Section 33. Tell the first group th
- Page 65 and 66: Section 32SECTION 3RESISTANCE AND A
- Page 67 and 68: Section 310. Conclude the session b
- Page 69 and 70: Section 43. Explain that we now kno
- Page 71 and 72: Section 42SECTION 4PREVENTION PRACT
- Page 75 and 76: SCHEDULE FOR DAY 3Day Three : Posit
- Page 77 and 78: Section 4Write responses from the p
- Page 79 and 80: Section 43SECTION 4POSITIVE PREVENT
- Page 81 and 82: Section 43SECTION 4POSITIVE PREVENT
- Page 83 and 84: Section 4f. Unroll the condom over
- Page 85 and 86: Section 43SECTION 4POSITIVE PREVENT
- Page 87 and 88: Section 4carry out our role as peer
- Page 89 and 90: Section 4consent) will only discour
- Page 91 and 92: Section 53SECTION 5COUNSELING ON AD
- Page 93 and 94: Section 53SECTION 5COUNSELING ON AD
- Page 95 and 96: Section 54. Summarize the game acti
- Page 97 and 98: Section 53SECTION 5COUNSELING ON AD
- Page 99 and 100:
Section 53SECTION 5COUNSELING ON AD
- Page 101 and 102:
Section 53SECTION 5COUNSELING ON AD
- Page 103 and 104:
Section 58. Ask the counseling team
- Page 105 and 106:
Section 53SECTION 5COUNSELING ON AD
- Page 107:
Section 5Questions for group two :P
- Page 110 and 111:
4SECTION 5Section 5COUNSELING ON AD
- Page 112 and 113:
4SECTION 5Section 5COUNSELING ON AD
- Page 114 and 115:
Section 5II. Issues specific to sex
- Page 116 and 117:
4SECTION 5Section 5COUNSELING ON AD
- Page 118 and 119:
Section 5h. Drug adherence is the m
- Page 120 and 121:
Section 6they are being discussed.2
- Page 122 and 123:
4SECTION 6Section 6CARE AND SUPPORT
- Page 124 and 125:
4SECTION 7Section 7POSITIVE LIVINGS
- Page 126 and 127:
4CARE AND SUPPORTSECTION 7Section 7
- Page 128 and 129:
4SECTION 8Section 8SERVICES FOR PLH
- Page 130 and 131:
Section 86. Conclude the session by
- Page 132 and 133:
Section 8Questions to be asked by t
- Page 134 and 135:
Section 8and questions to them out
- Page 136 and 137:
Section 8Group ThreeA patient who h
- Page 138 and 139:
Section 9had challenges in disclosi
- Page 140 and 141:
4SECTION 9Section 9SKILLS FOR PEER
- Page 142 and 143:
4SECTION 9Section 9SKILLS FOR PEER
- Page 144 and 145:
Section 9interest to share this inf
- Page 146 and 147:
Section 9Scenario 3.Sameer is a 26-
- Page 148 and 149:
Section 93. Explain that each of th
- Page 150 and 151:
Section 103. Ask a few volunteers t
- Page 152 and 153:
Section 104. If the evaluation is v
- Page 154 and 155:
Section 104 SECTION 10CLOSINGSESSIO
- Page 156 and 157:
Section 10PRE/POST TEST QUESTIONNAI
- Page 158 and 159:
PRE/POST TEST QUESTIONNAIRE-ANSWER
- Page 160 and 161:
NotesAdherence to Treatment for HIV
- Page 162:
Cover Concept: ‘Treatment informa